Andere talen GSK plc

Aandelen

GSK

GB00BN7SWP63

Farmaceutische producten

Geschatte realtime Cboe Europe Andere beurzen 17:30:00 18-06-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.448,50 ^GBX	-2,13%		-4,92%	+7,54%

17:34	Kennedy's nieuwe Amerikaanse vaccinatiepanel bespreekt mazelenprik voor kinderen	RE
17:16	CDC-adviescommissie stemt over vaccins tegen RSV en griep	RE

Andere talen

Kennedy's new US vaccine panel to discuss measles shot for children	17:34
CDC's vaccine advisory committee to vote on RSV, flu shots	17:16
Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May	17/06
Trump Administration to Consider Pharma Advertising Crackdown	17/06
Trump Administration to Consider Pharma Advertising Crackdown, Bloomberg reports	17/06
New B&M CEO Tjeerd Jegen buys GBP500,000 in shares	17/06
Stocks up on hopes of thaw to Middle East tension	16/06
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US	16/06
GSK plc Announces the Linked by Lupus: Optimal Care Initiative to Help Support Individuals with Lupus in the US	16/06
Alector, Inc. Announces Chief Financial Officer Changes	13/06
Moderna falls on doubts over new CDC panel's backing of RSV vaccine	13/06
Stocks slide, oil jumps after Israel strikes Iran	13/06
Moderna falls on doubts over new CDC panel's backing of RSV vaccine	13/06
Global markets live: Tesla, Google, Apple, Novo Nordisk, Boeing…	13/06
GSK Says EMA Accepts Application to Expand RSV Vaccine Use to Adults Above 18	13/06
GSK applies to EU regulator for expanded use of RSV vaccine	13/06
GSK: EMA accepts application for VRS	13/06
UK Stocks-UK Factors to watch on June 13	13/06
GSK's RSV drug Arexvy accepted for regulatory review in Europe	13/06
GSK plc's RSV Vaccine Accepts for Regulatory Review by the European Medicines Agency to Expand Use in Adults 18 Years and Older	13/06
PHP hits back after Assura backs KKR offer	13/06
PHP hits back after Assura backs KKR offer	13/06
GSK : RSV vaccine, Arexvy, accepted for regulatory review by the European Medicines Agency to expand use in adults 18 years and older	13/06
GSK says EU heath regulator reviewing expansion of RSV vaccine	13/06
GSK RSV Vaccine Arexvy Accepted For EMA Review To Expand Use	13/06

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

GSK PLC : Ondanks de uitdagingen blijft GSK een interessante belegging.

21 mei 2025 om 16:08 uur

GSK CEO over uitbreiding VS, fusies en overnames, medicijnpijplijn, Trump

13 januari 2025 om 21:03 uur

GSK plc: weer op koers

04 mei 2024 om 22:35 uur